Management of Pulmonary Arterial Hypertension in Primary Care: Advancing Patient Outcomes through Improved Diagnosis and Individualized Treatment

Management of Pulmonary Arterial Hypertension in Primary Care: Advancing Patient Outcomes through Improved Diagnosis and Individualized Treatment is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Oct 16, 2018 - Oct 16, 2019.

Intended Learners:
This activity is designed for primary care physicians, family medicine specialists, internists, pediatricians, nurse practitioners, nurses, physician assistants, pharmacists, registered dietitians, certified diabetes educators, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome.

Accreditation:

CME:
NACCME designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit.

Physician Assistants:
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 credit(s).

CPE:
This enduring activity is approved for .5 contact hour (.05 CEUs) of continuing pharmacy education (JA0006201-0000-18-198-H01-P).

Learning Objectives:
After completing this activity, participants should be able to:

• Describe the risk factors, clinical characteristics, and diagnostic criteria/classification of PAH for timely and accurate differential diagnosis
• Outline the etiologies and pathophysiology that underlie PAH and the resultant implications for therapeutic targeting
• Differentiate among available PAH-specific treatments with respect to their mechanisms of action, efficacy, safety, and indications
• Apply the latest clinical data, guideline recommendations, and therapeutic algorithms to facilitate the optimal identification, treatment, and referral of patients with PAH.

Additional details will be posted as soon as they are available.